drugset / Trial / NCT00116870
MARS - Monitored Atherosclerosis Regression Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether significant alterations in serum lipoproteins as provided by the drug lovastatin can substantially reduce atherosclerosis progression or even induce regression.
Timeline
- Start
- 1985-06
- Primary completion
- 1992-02
- Completion
- 1992-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovastatin | Small molecule | 40 mg | — |